HCW Biologics Inc (HCWB) with a beta value of 0.70 appears to be a promising investment opportunity.

Sana Meer

On Friday, HCW Biologics Inc (NASDAQ: HCWB) was 20.48% up from the session before settling in for the closing price of $2.49. A 52-week range for HCWB has been $2.34 – $100.80.

Healthcare Sector giant saw their annual sales slid by -29.55% over the last five years. When this article was written, the company’s average yearly earnings per share was at 91.82%. With a float of $1.63 million, this company’s outstanding shares have now reached $2.62 million.

HCW Biologics Inc (HCWB) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward HCW Biologics Inc stocks. The insider ownership of HCW Biologics Inc is 24.24%, while institutional ownership is 5.74%. The most recent insider transaction that took place on May 16 ’25, was worth 60,002. In this transaction Chief Executive Officer of this company bought 8,054 shares at a rate of $7.45, taking the stock ownership to the 501,911 shares. Before that another transaction happened on May 16 ’25, when Company’s Director bought 1,342 for $7.45, making the entire transaction worth $9,998. This insider now owns 4,075 shares in total.

HCW Biologics Inc (HCWB) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 91.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 57.65% during the next five years compared to -29.55% drop over the previous five years of trading.

HCW Biologics Inc (NASDAQ: HCWB) Trading Performance Indicators

You can see what HCW Biologics Inc (HCWB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.06. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.36.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -13.96, a number that is poised to hit -1.77 in the next quarter and is forecasted to reach -4.13 in one year’s time.

Technical Analysis of HCW Biologics Inc (HCWB)

Analysing the last 5-days average volume posted by the [HCW Biologics Inc, HCWB], we can find that recorded value of 0.38 million was lower than the volume posted last year of 0.82 million. As of the previous 9 days, the stock’s Stochastic %D was 19.43%.

During the past 100 days, HCW Biologics Inc’s (HCWB) raw stochastic average was set at 13.86%, which indicates a significant decrease from 43.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.34 in the past 14 days, which was lower than the 0.39 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.87, while its 200-day Moving Average is $7.29. Now, the first resistance to watch is $3.75. This is followed by the second major resistance level at $4.51. The third major resistance level sits at $5.23. If the price goes on to break the first support level at $2.27, it is likely to go to the next support level at $1.55. Now, if the price goes above the second support level, the third support stands at $0.79.

HCW Biologics Inc (NASDAQ: HCWB) Key Stats

There are 2,152K outstanding shares of the company, which has a market capitalization of 6.45 million. As of now, sales total 2,570 K while income totals -30,020 K. Its latest quarter income was 10 K while its last quarter net income were -1,930 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.